You have 9 free searches left this month | for more free features.

Viral-associated hemophagocytic syndrome (VAHS)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed
  • Acute Lymphoblastic Leukemia
  • +8 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,

Recruiting
  • Hemophagocytic Syndrome
  • T/NK-Cell Lymphoma
  • Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
Aug 3, 2021

COVID-19-Associated Encephalitis, Multisystem Inflammatory Syndrome in Children Trial in Taipei (delineate its prognostic

Recruiting
  • COVID-19-Associated Encephalitis
  • Multisystem Inflammatory Syndrome in Children
  • delineate its prognostic biomarker, host genetic factors, immunopathogenesis and viral pathogenesis
  • Taipei, Chung Cheng District, Taiwan
    National Taiwan University Hospital
Oct 12, 2022

COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction, COVID-19-Associated Thromboembolism Trial in Chongqing

Active, not recruiting
  • COVID-19 Stress Syndrome
  • +5 more
  • Atorvastatin Calcium Tablets
  • Chongqing, Chongqing, China
    Residential Address
May 1, 2023

HLH Trial in Beijing (Thiotepa)

Recruiting
  • HLH
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
May 10, 2023

Covid19, ARDS, Pneumonia, Viral Trial in United States (DB-001, Intravenous normal saline)

Completed
  • Covid19
  • +2 more
  • DB-001
  • Intravenous normal saline
  • Sheffield, Alabama
  • +4 more
Jan 13, 2022

EBV Infection Trial in Suzhou (PD-1 mAb)

Recruiting
  • EBV Infection
  • PD-1 monoclonal antibody
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 1, 2021

Associated Burden of Related Conditions in Alopecia Areata

Completed
  • Alopecia Areata
  • +35 more
  • Exposure of interest (studies 2 & 3).
  • London, United Kingdom
    Momentum Data Ltd
Dec 13, 2022

Prognosis and Therapeutic Decision Tool for Autoimmunity and

Not yet recruiting
  • Autoimmune Lymphoproliferative Syndrome
  • +19 more
  • Collection of samples
  • (no location specified)
May 26, 2021

EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV-associated Hemophagocytic Lymphohistiocytosis
  • EBV Infection
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 12, 2023

Prospective Validation of the OHI Index

Recruiting
  • HLH
  • +4 more
    • Kfar Saba, Israel
    • +1 more
    May 21, 2023

    Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

    Recruiting
    • Secondary Hemophagocytic Lymphohistiocytosis
    • Chronic Active Epstein-Barr Virus Infection
    • No intervention
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    May 2, 2023

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      Children and Adult Hemophagocytic Syndrome (HLHa)

      Completed
      • Hemophagocytic Syndrome
      • Identification of biological markers
      • Paris, France
        Clinical Research Unit
      Nov 19, 2021

      Lymphoma-associated Hemophagocytic Lymphohistiocytosis

      Recruiting
      • Lymphoma
      • Hemophagocytic Lymphohistiocytoses
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Jun 1, 2023

        Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
        • Innsbruck, Austria
        • +9 more
        Oct 24, 2022

        PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • PD-1 Antibody
        • +3 more
        • L-DEP and PD-1 antibody
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Mar 8, 2023

        Adult Hemophagocytic Lymphohistiocytosis in Critically Ill

        Recruiting
        • Hemophagocytic Lymphohistiocytosis
          • Berlin, Germany
            Department of Anesthesiology and Operative Intensive Care Medici
          Jul 13, 2021

          Covid19, SARS (Severe Acute Respiratory Syndrome), SARS Pneumonia Trial in Worldwide (Fostamatinib, Placebo)

          Active, not recruiting
          • Covid19
          • +5 more
          • Orange, California
          • +46 more
          Aug 9, 2022

          Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)

          Not yet recruiting
          • Hemophagocytic Lymphohistiocytoses
          • Lymphoma
          • cytokine
          • Beijing, Beijing, China
            Zhao Wang
          Oct 27, 2022

          Cytokine Storm, COVID-19 Trial in Birmingham (Anakinra, Normal saline)

          Active, not recruiting
          • Cytokine Storm
          • COVID-19
          • Birmingham, Alabama
            University of Alabama at Birmingham
          Jan 23, 2023

          Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)

          Not yet recruiting
          • Hemophagocytic Lymphohistiocytoses
          • +2 more
          • observational
          • Beijing, Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Dec 22, 2022

          Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

          Not yet recruiting
          • Carbapenem Resistant Bacterial Infection
          • Hemophagocytic Lymphohistiocytoses
          • Carrimycin tablets
          • Beijing, Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Aug 4, 2023

          COVID-19, Acute Respiratory Distress Syndrome, Virus; Pneumonia Trial in Beijing (CAStem)

          Unknown status
          • COVID-19
          • +3 more
          • CAStem
          • Beijing, Beijing, China, China
            Beijing YouAn Hospital, Capital Medical University
          Mar 31, 2020

          Covid19, SARS-CoV Infection Trial in United States (Metformin, Placebo, Fluvoxamine)

          Active, not recruiting
          • Covid19
          • SARS-CoV Infection
          • Sylmar, California
          • +6 more
          Aug 5, 2022